{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:30:10Z","timestamp":1790227810395,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00213-012-2722-0","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T13:50:51Z","timestamp":1335793851000},"page":"345-355","source":"Crossref","is-referenced-by-count":58,"title":["NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice"],"prefix":"10.1007","volume":"223","author":[{"given":"Mohammad","family":"Salehi-Sadaghiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrak","family":"Javadi-Paydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Gharedaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zandieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Heydarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashar","family":"Yousefzadeh-fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pscychresns.2006.11.002","volume":"155","author":"M Aihara","year":"2007","unstructured":"Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H (2007) HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic\/paralimbic regions. Psychiatry Res Neuroimaging 155:245\u2013256","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2722_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1742-7843.2007.00127.x","volume":"101","author":"M Allahtavakoli","year":"2007","unstructured":"Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A (2007) Combination therapy of rosiglitazone, a peroxisome proliferator activated receptor ligand, and NMDA receptor antagonist (MK 801) on experimental embolic stroke in rats. Basic Clin Pharmacol Toxicol 101:309\u2013314","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2722_CR3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes. Diabetes Care 24:1069","journal-title":"Diabetes Care"},{"key":"2722_CR4","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1167\/iovs.02-1060","volume":"44","author":"P Aoun","year":"2003","unstructured":"Aoun P, Simpkins JW, Agarwal N (2003) Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Investig Ophthalmol Vis Sci 44:2999","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2722_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1370\/afm.349","volume":"3","author":"B Arroll","year":"2005","unstructured":"Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I (2005) Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 3:449\u2013456","journal-title":"Ann Fam Med"},{"key":"2722_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1741-7015-9-134","volume":"9","author":"AJ Baxter","year":"2011","unstructured":"Baxter AJ, Charlson FJ, Somerville AJ, Whiteford HA (2011) Mental disorders as risk factors: assessing the evidence for the global burden of disease study. BMC Med 9:134","journal-title":"BMC Med"},{"key":"2722_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"2722_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","volume":"34","author":"R Bordet","year":"2006","unstructured":"Bordet R, Ouk T, Petrault O, Gele P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart JC, Bastide M (2006) PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 34:1341\u20131346","journal-title":"Biochem Soc Trans"},{"key":"2722_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/CT:6:2:111","volume":"6","author":"AR Brasier","year":"2006","unstructured":"Brasier AR (2006) The NF-kappaB regulatory network. Cardiovasc Toxicol 6:111\u2013130","journal-title":"Cardiovasc Toxicol"},{"key":"2722_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbr.2009.01.004","volume":"200","author":"PS Brocardo","year":"2009","unstructured":"Brocardo PS, Budni J, Lobato KR, Santos ARS, Rodrigues ALS (2009) Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test. Behav Brain Res 200:122\u2013127","journal-title":"Behav Brain Res"},{"key":"2722_CR11","doi-asserted-by":"crossref","unstructured":"Budni J, Lobato KR, Binfare RW, Freitas AE, Costa AP, Saavedra MD, Leal RB, Lopez MG, Rodrigues AL (2011) Involvement of PI3K, GSK-3beta and PPARgamma in the antidepressant-like effect of folic acid in the forced swimming test in mice. J Psychopharmacol. doi: 10.1177\/0269881111424456","DOI":"10.1177\/0269881111424456"},{"key":"2722_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1358\/dnp.2010.23.9.1513493","volume":"23","author":"SI Cho","year":"2010","unstructured":"Cho SI, Park UJ, Chung JM, Gwag BJ (2010) Neu 2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke. Drug News Perspect 23:549\u2013556","journal-title":"Drug News Perspect"},{"key":"2722_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuroscience.2004.09.043","volume":"130","author":"A Cimini","year":"2005","unstructured":"Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'amico M, D'angelo B, Di Loreto S (2005) Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130:325\u2013337","journal-title":"Neuroscience"},{"key":"2722_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euroneuro.2006.01.003","volume":"16","author":"FT Consoni","year":"2006","unstructured":"Consoni FT, Vital MABF, Andreatini R (2006) Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 16:451\u2013458","journal-title":"Eur Neuropsychopharmacol"},{"key":"2722_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"2722_CR16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006842-200107000-00015","volume":"63","author":"M Groot De","year":"2001","unstructured":"De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619","journal-title":"Psychosom Med"},{"key":"2722_CR17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","volume":"88","author":"T Dehmer","year":"2004","unstructured":"Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494\u2013501","journal-title":"J Neurochem"},{"key":"2722_CR18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/FBP.0b013e328331b9bf","volume":"20","author":"AA Eissa Ahmed","year":"2009","unstructured":"Eissa Ahmed AA, Al-Rasheed NM (2009) Antidepressant-like effects of rosiglitazone, a PPARgamma agonist, in the rat forced swim and mouse tail suspension tests. Behav Pharmacol 20:635\u2013642","journal-title":"Behav Pharmacol"},{"key":"2722_CR19","doi-asserted-by":"crossref","unstructured":"Esplugues JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135:1079\u20131095","DOI":"10.1038\/sj.bjp.0704569"},{"key":"2722_CR20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.10206","volume":"51","author":"DL Feinstein","year":"2002","unstructured":"Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT (2002) Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol 51:694\u2013702","journal-title":"Ann Neurol"},{"key":"2722_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0079-6123(10)83009-2","volume":"183","author":"F Gardoni","year":"2010","unstructured":"Gardoni F, Ghiglieri V, Luca M, Calabresi P (2010) Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease. Prog Brain Res 183:169\u2013182","journal-title":"Prog Brain Res"},{"key":"2722_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","volume":"68","author":"DS Geldmacher","year":"2011","unstructured":"Geldmacher DS, Fritsch T, McClendon MJ, Landreth G (2011) A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease. Arch Neurol 68:45\u201350","journal-title":"Arch Neurol"},{"key":"2722_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","volume":"206","author":"M Ghasemi","year":"2009","unstructured":"Ghasemi M, Montaser-Kouhsari L, Shafaroodi H, Nezami BG, Ebrahimi F, Dehpour AR (2009) NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology (Berl) 206:325\u2013333","journal-title":"Psychopharmacology (Berl)"},{"key":"2722_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/0269881109104845","volume":"24","author":"M Ghasemi","year":"2010","unstructured":"Ghasemi M, Raza M, Dehpour AR (2010) NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. J Psychopharmacol 24:585\u2013594","journal-title":"J Psychopharmacol"},{"key":"2722_CR25","first-page":"1229","volume":"59","author":"O Gonzalez","year":"2010","unstructured":"Gonzalez O, Berry J, McKnight-Eily L, Strine T, Edwards V, Lu H, Croft J (2010) Current depression among adults: United States, 2006 and 2008. Morb Mortal Wkly Rev 59:1229\u20131235","journal-title":"Morb Mortal Wkly Rev"},{"key":"2722_CR26","doi-asserted-by":"crossref","unstructured":"Hara MR, Snyder SH (2007) Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 47:117\u2013141","DOI":"10.1146\/annurev.pharmtox.47.120505.105311"},{"key":"2722_CR27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","volume":"35","author":"L Ibrahim","year":"2011","unstructured":"Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, Zarate CA Jr (2011) Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 35:1155\u20131159","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2722_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.arcmed.2009.05.005","volume":"40","author":"Y Ji-Rong","year":"2009","unstructured":"Ji-Rong Y, Bi-Rong D, Chang-Quan H, Zhen-Chan L, Hong-Mei W, Yan-Ling Z, Mattis TA (2009) Pro12Ala polymorphism in PPAR [gamma] 2 associated with depression in Chinese nonagenarians\/centenarians. Arch Med Res 40:411\u2013415","journal-title":"Arch Med Res"},{"key":"2722_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3371\/CSRP.4.3.6","volume":"4","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Javitt DC (2010) Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin Schizophr Relat Psychoses 4:189\u2013200","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"2722_CR30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11606-008-0731-9","volume":"23","author":"W Katon","year":"2008","unstructured":"Katon W, Fan MY, Un\u00fctzer J, Taylor J, Pincus H, Schoenbaum M (2008) Depression and diabetes: a potentially lethal combination. J Gen Intern Med 23:1571\u20131575","journal-title":"J Gen Intern Med"},{"key":"2722_CR31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ajp.2008.08081195","volume":"166","author":"DE Kemp","year":"2009","unstructured":"Kemp DE, Ismail-Beigi F, Calabrese JR (2009) Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry 166:619","journal-title":"Am J Psychiatry"},{"key":"2722_CR32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","volume":"136","author":"DE Kemp","year":"2011","unstructured":"Kemp DE, Ismail-Beigi F, Ganocy SJ, Conroy C, Gao K, Obral S, Fein E, Findling RL, Calabrese JR (2011) Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord 136:1164\u20131173","journal-title":"J Affect Disord"},{"key":"2722_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.clinpsy.3.022806.091444","volume":"3","author":"RC Kessler","year":"2007","unstructured":"Kessler RC, Merikangas KR, Wang PS (2007) Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol 3:137\u2013158","journal-title":"Annu Rev Clin Psychol"},{"key":"2722_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","volume":"191","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Chen J, Calingasan NY, Beal MF (2005) Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 191:331\u2013336","journal-title":"Exp Neurol"},{"key":"2722_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5618.2008.00435.x","volume":"10","author":"JZ Konarski","year":"2008","unstructured":"Konarski JZ, McIntyre RS, Kennedy SH, Rafi Tari S, Soczynska JK, Ketter TA (2008) Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 10:1\u201337","journal-title":"Bipolar Disord"},{"key":"2722_CR36","doi-asserted-by":"crossref","first-page":"403896","DOI":"10.1155\/2008\/403896","volume":"2008","author":"MP Kummer","year":"2008","unstructured":"Kummer MP, Heneka MT (2008) PPARs in Alzheimer\u2019s disease. PPAR Res 2008:403896","journal-title":"PPAR Res"},{"key":"2722_CR37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","volume":"16","author":"SE Laursen","year":"1986","unstructured":"Laursen SE, Belknap JK (1986) Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16:355\u2013357","journal-title":"J Pharmacol Methods"},{"key":"2722_CR38","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953\u201312956","journal-title":"J Biol Chem"},{"key":"2722_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","volume":"343","author":"M Mantovani","year":"2003","unstructured":"Mantovani M, Pertile R, Calixto JB, Santos AR, Rodrigues AL (2003) Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine\u2013nitric oxide pathway. Neurosci Lett 343:1\u20134","journal-title":"Neurosci Lett"},{"key":"2722_CR40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0004.2010.01610.x","volume":"79","author":"M Metzler","year":"2011","unstructured":"Metzler M (2011) Mutations in NMDA receptors influence neurodevelopmental disorders causing epilepsy and intellectual disability. Clin Genet 79:219\u2013220","journal-title":"Clin Genet"},{"key":"2722_CR41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","volume":"33","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Raymond LA (2010) Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci 33:513\u2013523","journal-title":"Trends Neurosci"},{"key":"2722_CR42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pnpbp.2007.09.004","volume":"32","author":"M Molina-Hernandez","year":"2008","unstructured":"Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, Olivera-Lopez JI, Jaramillo-Jaimes MT (2008) Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 32:380\u2013386","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2722_CR43","doi-asserted-by":"crossref","unstructured":"Moncada S, Palmer R, Higgs E (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109\u2013142","DOI":"10.1016\/S0031-6997(25)06663-3"},{"key":"2722_CR44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2008001200001","volume":"41","author":"CD Munhoz","year":"2008","unstructured":"Munhoz CD, Garcia-Bueno B, Madrigal JL, Lepsch LB, Scavone C, Leza JC (2008) Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 41:1037\u20131046","journal-title":"Braz J Med Biol Res"},{"key":"2722_CR45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-007-0873-z","volume":"51","author":"DM Nathan","year":"2008","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B (2008) Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 51:8\u201311","journal-title":"Diabetologia"},{"key":"2722_CR46","doi-asserted-by":"crossref","unstructured":"Paul IA, Skolnick P (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003:250\u2013272","DOI":"10.1196\/annals.1300.016"},{"key":"2722_CR47","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1471-4159.2009.06107.x","volume":"109","author":"T Pancani","year":"2009","unstructured":"Pancani T, Phelps JT, Searcy JL, Kilgore MW, Chen KC, Porter NM, Thibault O (2009) Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons. J Neurochem 109:1800\u20131811","journal-title":"J Neurochem"},{"key":"2722_CR48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.jcbfm.9600182","volume":"26","author":"MP Pereira","year":"2006","unstructured":"Pereira MP, Hurtado O, Cardenas A, Bosca L, Castillo J, Davalos A, Vivancos J, Serena J, Lorenzo P, Lizasoain I, Moro MA (2006) Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26:218\u2013229","journal-title":"J Cereb Blood Flow Metab"},{"key":"2722_CR49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2007.07.018","volume":"88","author":"E Poleszak","year":"2007","unstructured":"Poleszak E, Wlaz P, Kedzierska E, Nieoczym D, Wrobel A, Fidecka S, Pilc A, Nowak G (2007) NMDA\/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 88:158\u2013164","journal-title":"Pharmacol Biochem Behav"},{"key":"2722_CR50","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2722_CR51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jn\/136.3.700","volume":"136","author":"MK Racke","year":"2006","unstructured":"Racke MK, Gocke AR, Muir M, Diab A, Drew PD, Lovett-Racke AE (2006) Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. J Nutr 136:700\u2013703","journal-title":"J Nutr"},{"key":"2722_CR52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12640-010-9203-1","volume":"19","author":"P Riederer","year":"2011","unstructured":"Riederer P, Bartl J, Laux G, Gr\u00fcnblatt E (2011) Diabetes type II: a risk factor for depression\u2013Parkinson\u2013Alzheimer? Neurotox Res 19:253\u2013265","journal-title":"Neurotox Res"},{"key":"2722_CR53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-4328(03)00069-X","volume":"144","author":"AO Rosa","year":"2003","unstructured":"Rosa AO, Lin J, Calixto JB, Santos ARS, Rodrigues ALS (2003) Involvement of NMDA receptors and l-arginine\u2013nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144:87\u201393","journal-title":"Behav Brain Res"},{"key":"2722_CR54","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","volume":"32","author":"AO Rosa","year":"2008","unstructured":"Rosa AO, Kaster MP, Binfare RW, Morales S, Martin-Aparicio E, Navarro-Rico ML, Martinez A, Medina M, Garcia AG, Lopez MG, Rodrigues AL (2008) Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 32:1549\u20131556","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2722_CR55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","volume":"224","author":"MS Sadaghiani","year":"2011","unstructured":"Sadaghiani MS, Javadi-Paydar M, Gharedaghi MH, Fard YY, Dehpour AR (2011) Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Behav Brain Res 224:336\u2013343","journal-title":"Behav Brain Res"},{"key":"2722_CR56","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","volume":"29","author":"N Schintu","year":"2009","unstructured":"Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR (2009) PPAR gamma mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease. Eur J Neurosci 29:954\u2013963","journal-title":"Eur J Neurosci"},{"key":"2722_CR57","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","volume":"25","author":"B Schutz","year":"2005","unstructured":"Schutz B, Reimann J, Dumitrescu-Ozimek L, Kappes-Horn K, Landreth GE, Schurmann B, Zimmer A, Heneka MT (2005) The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J Neurosci 25:7805\u20137812","journal-title":"J Neurosci"},{"key":"2722_CR58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","volume":"30","author":"P Skolnick","year":"2009","unstructured":"Skolnick P, Popik P, Trullas R (2009) Glutamate-based antidepressants: 20\u00a0years on. Trends Pharmacol Sci 30:563\u2013569","journal-title":"Trends Pharmacol Sci"},{"key":"2722_CR59","doi-asserted-by":"crossref","unstructured":"Tokita K, Yamaji T, Hashimoto K (2011) Roles of glutamate signaling in preclinical and\/or mechanistic models of depression. Pharmacol Biochem Behav","DOI":"10.1016\/j.pbb.2011.04.016"},{"key":"2722_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","volume":"185","author":"R Trullas","year":"1990","unstructured":"Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"2722_CR61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-4598-10-12","volume":"10","author":"R Wilken","year":"2011","unstructured":"Wilken R, Veena MS, Wang MB, Srivatsan ES (2011) Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12","journal-title":"Mol Cancer"},{"key":"2722_CR62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2006.09.010","volume":"29","author":"K Yaffe","year":"2008","unstructured":"Yaffe K, Kanaya A, Lindquist K, Hsueh W, Cummings S, Beamer B, Newman A, Rosano C, Li R, Harris T (2008) PPAR-[gamma] Pro12Ala genotype and risk of cognitive decline in elders. Neurobiol Aging 29:78\u201383","journal-title":"Neurobiol Aging"},{"key":"2722_CR63","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"H Yki-J\u00e4rvinen","year":"2004","unstructured":"Yki-J\u00e4rvinen H (2004) Thiazolidinediones. N Engl J Med 351:1106\u20131118","journal-title":"N Engl J Med"},{"key":"2722_CR64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"2722_CR65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/11538250-000000000-00000","volume":"27","author":"D Zekry","year":"2010","unstructured":"Zekry D, Gold G (2010) Management of mixed dementia. Drugs Aging 27:715\u2013728","journal-title":"Drugs Aging"},{"key":"2722_CR66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.24.2.170","volume":"24","author":"F Zhang","year":"1994","unstructured":"Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD (1994) Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24:170\u2013175","journal-title":"Hypertension"},{"key":"2722_CR67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","volume":"1073","author":"X Zhao","year":"2006","unstructured":"Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J (2006) Peroxisome-proliferator-activated receptor-gamma (PPAR [gamma]) activation protects neurons from NMDA excitotoxicity. Brain Res 1073:460\u2013469","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2722-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2722-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:48:50Z","timestamp":1743029330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2722-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}